NCT03108534View on ClinicalTrials.gov

A Study to Evaluate the Onset of Relief From Methacholine-induced Bronchoconstriction With CHF1535 NEXThaler in Asthmatic Patients.

PHASE2CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

February 28, 2017

Primary Completion Date

September 19, 2017

Study Completion Date

September 19, 2017

Conditions
Asthma
Interventions
DRUG

CHF1535 NEXThaler

Rescue treatment

DRUG

CHF1535 pMDI

Rescue treatment

DRUG

Placebo

Rescue treatment

Trial Locations (3)

Unknown

University of Dundee, Dundee

Hammersmith Medicines Research, London

Medicines Evaluation Unit, Manchester

All Listed Sponsors
lead

Chiesi Farmaceutici S.p.A.

INDUSTRY

NCT03108534 - A Study to Evaluate the Onset of Relief From Methacholine-induced Bronchoconstriction With CHF1535 NEXThaler in Asthmatic Patients. | Biotech Hunter | Biotech Hunter